Ethical framework for head and neck cancer care impacted by COVID-19. Head Neck 2020 Jun;42(6):1214-1217
Date
04/25/2020Pubmed ID
32329948Pubmed Central ID
PMC7264503DOI
10.1002/hed.26193Scopus ID
2-s2.0-85084212370 (requires institutional sign-in at Scopus site) 21 CitationsAbstract
The COVID-19 pandemic has upended head and neck cancer care delivery in ways unforeseen and unprecedented. The impact of these changes parallels other fields in oncology, but is disproportionate due to protective measures and limitations on potentially aerosolizing procedures and related interventions specific to the upper aerodigestive tract. The moral and professional dimensions of providing ethically appropriate and consistent care for our patients in the COVID-19 crisis are considered herein for head and neck oncology providers.
Author List
Shuman AG, Campbell BH, AHNS Ethics & Professionalism ServiceAuthor
Bruce H. Campbell MD Emeritus Professor in the Otolaryngology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Coronavirus InfectionsDisease Management
Female
Head and Neck Neoplasms
Humans
Male
Medical Oncology
Pandemics
Patient Care Planning
Pneumonia, Viral
Risk Assessment
United States